Oxford Nanopore Technologies is looking forward to “the year of the proteome,” as co-founder and CEO Gordon Sanghera, PhD, labeled 2025 during his presentation at the recent 43rd Annual J.P. Morgan ...
OXFORD, United Kingdom--(BUSINESS WIRE)--Oxford Nanopore Technologies plc (Oxford Nanopore), the company delivering a new generation of nanopore-based molecular sensing technology, and Saphetor, the ...
OXFORD, England--(BUSINESS WIRE)--Oxford Nanopore Technologies plc (Oxford Nanopore), the company delivering a new generation of nanopore-based molecular sensing technology, and Geneyx, an AI platform ...
Oxford Nanopore Technologies has signed a partnership with artificial intelligence developer SeqOne to support its next-generation sequencing approach in clinical diagnostic testing. The goal will be ...
Infectious disease poses a threat to human health and is becoming more dangerous with increasing urbanization, population growth, and climate change. Fortunately, genomic sequencing technologies have ...
This short video introduces antimicrobial resistance (AMR) and highlights how Oxford Nanopore technology can resolve whole bacterial genomes to find AMR genes within hours. This rapid identification ...
Epigenetics is the study of chemical modifications that can alter phenotype without altering nucleotide sequence. The most well-characterized and widely studied epigenetic modification in mammalian ...
David Deamer (left) and Mark Akeson in Santa Cruz in 2023 after receiving the inaugural UCSC Chancellor’s Innovation Impact Award for inventing nanopore sequencing. Today, two UC Santa Cruz ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results